Tai Sandi See

Chief Development Officer, Lexeo Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.0M

Companies

Latest trade

Nov 18, 2025

Companies

Lexeo Therapeutics, Inc.Chief Development Officer −$0.0M

Trades

LXEO Sold 386 shares at $9.27 $0.0M Nov 18

LXEO Sold 3,888 shares at $8.95 $0.0M Oct 17

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.